Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in JAZZ — Jazz Pharmaceuticals plc

CIK 1423053 MIAMI, FL
Back to JAZZ Full portfolio

Position in JAZZ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$242,578,715
+$4,480,828 QoQ
Shares Held
1,006,676
-20.1% QoQ
Ownership
1.55%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#17
of 629 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in JAZZ Over Time

Shares Held

Position Value (USD)

Derivatives in JAZZ

reported options exposure · as of Jun 30, 2026
CallValue
$11,253,299
CallShares
46,700
PutValue
$7,783,331
PutShares
32,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,678,386 across 436 Biotechnology names. JAZZ ranks #6 (4.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
This page 		1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in JAZZ

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,253,299 46,700
2026-06-30 $7,783,331 32,300
2026-06-30 $242,578,715 1,006,676
2026-03-31 $4,612,820 24,400
2026-03-31 $238,097,887 1,259,444
2026-03-31 $11,361,905 60,100
2025-12-31 $52,890,400 311,120
2025-12-31 $11,679,000 68,700
2025-12-31 $4,165,000 24,500
2025-09-30 $5,364,260 40,700
2025-09-30 $1,041,220 7,900
2025-09-30 $116,503,950 883,945
2025-06-30 $66,024,892 622,172
2025-06-30 $435,092 4,100
2025-06-30 $4,552,548 42,900
2025-03-31 $86,525,597 696,944
2025-03-31 $4,059,705 32,700
2025-03-31 $1,092,520 8,800
2024-12-31 $1,059,090 8,600
2024-12-31 $62,356,755 506,348
2024-12-31 $2,155,125 17,500
2024-09-30 $1,582,022 14,200
2024-09-30 $117,372,774 1,053,521
2024-09-30 $3,409,146 30,600
2024-06-30 $1,846,429 17,300
2024-06-30 $41,485,843 388,699
2024-06-30 $3,863,626 36,200
2024-03-31 $1,770,174 14,700
2024-03-31 $1,283,315 10,657
2024-03-31 $2,468,610 20,500
2023-12-31 $5,043,000 41,000
2023-12-31 $3,722,718 30,266
2023-12-31 $4,268,100 34,700
2023-09-30 $3,753,760 29,000
2023-09-30 $1,812,160 14,000
2023-09-30 $1,939,528 14,984
2023-06-30 $12,744,115 102,800
2023-06-30 $3,347,190 27,000
2023-06-30 $2,095,093 16,900
2023-03-31 $3,102,196 21,200
2023-03-31 $1,755,960 12,000
2023-03-31 $39,885,021 272,569
2022-12-31 $3,793,489 23,812
2022-12-31 $100,124,422 628,488
2022-12-31 $2,110,538 13,248
2022-09-30 $2,152,366 16,148
2022-09-30 $13,637,166 102,312
2022-06-30 $1,068,356 6,848
2022-06-30 $110,334,327 707,226
2022-06-30 $3,042,195 19,500

Report a Problem

Category
Description
Email (optional, for follow-up)